查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827920

植物性因體學市場按產品類型、技術、服務模式、應用和最終用戶分類－2025-2032 年全球預測

Plant Genomics Market by Product Type, Technology, Service Model, Application, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年植物性因組學市場將成長至 230.9 億美元，複合年成長率為 9.50%。

主要市場統計數據
基準年2024年 111.6億美元
預計2025年 122.3億美元
預測年份：2032年 230.9億美元
複合年成長率（%） 9.50%

植物性因組學策略入門指南，涵蓋農業、診斷和研究領域的技術整合、業務重點和相關人員需求

植物性因組學處於生物學、資料科學和農業創新的交叉點，其不斷擴展的套件正在重新定義相關人員追求生產力、韌性和診斷洞察力的方式。編輯平台、擴增和定序技術的進步正在逐步降低技術壁壘，使更廣泛的組織能夠將基因組學整合到育種計劃、診斷工作流程和基礎研究中。隨著這種轉變，對資料管理、可重複性和監管清晰度的日益重視正在塑造整個價值鏈的投資重點和營運選擇。

隨著該領域的成熟，研究人員需要應對日益複雜的供應商網路、不斷發展的基因工具部署標準以及對穩健生物資訊流程日益成長的需求。為此，多學科團隊正在圍繞模組化工作流程進行重組，以連接儀器、試劑、分析軟體和服務。這種整合方法提高了通量和可解釋性，同時也凸顯了對靈活籌資策略和熟練人才的需求，這些人才能夠將基因組學成果轉化為農業、診斷和探索研究的可行決策。

技術突破、不斷變化的監管預期以及以服務為中心的模式如何重塑植物性因組學研究的策略重點和營運工作流程

在方法學突破、監管格局變化以及終端用戶期望不斷提升的推動下，植物性因組學領域正在經歷一場變革性轉變。基因編輯技術正從利基實驗工具轉變為性狀開發的實用工具，促使下游育種策略和智慧財產權管理做出調整。同時，定序平台提供的資料集越來越豐富、越來越複雜，因此需要對可擴展儲存、標準化資料格式以及支援交叉研究比較和轉換應用的分析框架進行投資。

同時，企業越來越重視成果而非內部設備，這導致了向服務和軟體的轉變。這一趨勢正在推動將專業濕實驗室能力與先進運算能力相結合的協作模式。供應鏈彈性和採購透明度正在推動人們重新思考採購慣例。這些因素共同深刻地改變了企業分配資本、設計實驗和建立夥伴關係的方式。

評估近期關稅行動對植物性因組學工作流程中的採購、協作和供應連續性的營運和物流影響

近期影響進出口的關稅措施為植物性因組學生態系統帶來了新的摩擦，影響了設備、試劑和軟體許可證的採購。對於依賴跨境定序設備和專用試劑供應的實驗室來說，與關稅相關的成本調整可能會導致採購計畫和資本計畫的調整。這些變化可能會影響實驗室的吞吐量和新計畫的啟動速度，尤其對於那些按照津貼週期和季節性農業時間表運作的研究機構。

除了直接的成本影響外，關稅還可能使依賴樣品、耗材和模組化儀器組件及時運輸的合作研究安排變得複雜。因此，越來越多的團隊正在考慮本地採購替代方案、延長前置作業時間以及合約保障措施，以保持研究的連續性。貿易措施也提高了一些相關人員為降低風險而採取的本地製造和分銷策略的知名度。重要的是，與關稅引入相關的監管和海關流程可能會增加生物材料和硬體的清關時間。

深度細分洞察揭示了產品類型、技術平台、服務模式、應用和最終用戶如何在植物性因組學中創造差異化的價值池

對市場區隔的細緻理解，能夠揭示價值創造點以及哪些能力值得投資。相關人員根據產品類型將市場分為儀器、試劑和耗材、服務和軟體，每種類型都有不同的採購週期和支援預期。儀器需要資本規劃和長期服務契約，試劑和耗材會帶來經常性支出和品管問題，服務為缺乏內部能力的實驗室提供以結果為導向的能力，軟體則支援數據處理、可視化和決策支援。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • CRISPR-Cas介導的基因編輯技術進展使耐旱作物品種能夠適應氣候
  • 整合人工智慧和機器學習，加速植物性狀發現過程
  • 開發用於分析植物壓力反應的高通量單細胞定序平台
  • 商業化精準基因編輯技術以提高作物產量和營養價值
  • 泛基因組分析揭示主要穀物作物的遺傳多樣性
  • 應用標靶表觀基因編輯工具控制植物生長和環境耐受性
  • 利用綜合多組體學資料預測育種計劃中複雜性狀的遺傳
  • 擴大合成生物學方法以提高主要作物的光合作用效率
  • 可攜式奈米孔定序系統在農業領域即時病原體檢測的應用
  • 影響基因改造植物產品接受度的全球監管協調努力

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：植物性因體學市場（依產品類型）

  • 裝置
  • 試劑和耗材
  • 服務
  • 軟體

第9章植物性因體學市場（依技術）

  • 基因編輯
    • CRISPR
    • 轉錄活化因子樣效應核酸酶
    • 鋅指核酸酶
  • 聚合酵素鏈鎖反應
    • 數位聚合酵素鏈鎖反應
    • 定量聚合酵素鏈鎖反應
    • 逆轉錄聚合酵素鏈鎖反應
  • 定序
    • 次世代定序
    • 桑格定序
    • 第三代定序

第 10 章：植物性因體學市場（依服務模式）

  • 諮詢
  • 合約調查
  • 數據分析

第 11 章植物性因體學市場（按應用）

  • 農業
    • 抗病性
    • 遺傳改良
    • 產量提高
  • 診斷
    • 基因檢測
    • 傳染病檢查
    • 產前檢查
  • 調查
    • 基礎研究
    • 生物標記發現
    • 藥物研發

第 12 章植物性因體學市場（按最終用戶）

  • 學術研究機構
  • 農業企業
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第13章植物性因體學市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章植物性因體學市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按國家/地區分類的植物性因組學市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • BGI Genomics Co., Ltd.
    • QIAGEN NV
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Limited
    • Eurofins Scientific SE
    • Merck KGaA
Product Code: MRR-4316E4E8911B

The Plant Genomics Market is projected to grow by USD 23.09 billion at a CAGR of 9.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.16 billion
Estimated Year [2025] USD 12.23 billion
Forecast Year [2032] USD 23.09 billion
CAGR (%) 9.50%

A strategic primer on plant genomics that frames technological integration, operational priorities, and stakeholder needs across agriculture, diagnostics, and research

Plant genomics stands at the intersection of biology, data science, and agricultural innovation, and its expanding toolkit is redefining how stakeholders pursue productivity, resilience, and diagnostic insight. Advances in editing platforms, amplification techniques, and sequencing technologies have progressively lowered technical barriers, enabling a broader set of organizations to integrate genomics into breeding programs, diagnostic workflows, and foundational research. This shift is accompanied by a growing emphasis on data management, reproducibility, and regulatory clarity, which together shape investment priorities and operational choices across the value chain.

As the discipline matures, practitioners are navigating increasingly complex supplier networks, evolving standards for genetic tool deployment, and a heightened demand for robust bioinformatics pipelines. In response, cross-disciplinary teams are reorganizing around modular workflows that connect instruments, reagents, analytical software, and services. This integrated approach enhances throughput and interpretability, while also highlighting the need for adaptable procurement strategies and skilled personnel who can translate genomic outputs into actionable decisions for agriculture, diagnostics, and discovery research.

How technological breakthroughs, evolving regulatory expectations, and service-centric models are reshaping strategic priorities and operational workflows in plant genomics

The plant genomics landscape is experiencing transformative shifts driven by methodological breakthroughs, changes in regulatory postures, and evolving end-user expectations. Gene editing technologies have moved from niche experimental tools to practical instruments for trait development, prompting downstream adjustments in breeding strategies and intellectual property management. At the same time, sequencing platforms are delivering richer and more complex datasets, requiring investment in scalable storage, standardized data formats, and analytical frameworks that can support cross-study comparisons and translational applications.

Concurrently, services and software are gaining prominence as organizations prioritize outcomes over in-house instrumentation. This trend encourages collaborative models that pair specialized wet-lab capabilities with advanced computational offerings. Supply chain resilience and sourcing transparency are elevated concerns, prompting a reconsideration of procurement practices. Taken together, these forces are reshaping how organizations allocate capital, design experiments, and structure partnerships, emphasizing agility and downstream value realization over isolated technology acquisition.

Assessing the operational and logistical ripple effects of recent tariff measures on procurement, collaboration, and supply continuity within plant genomics workflows

Recent tariff measures affecting imports and exports have introduced new frictions across the plant genomics ecosystem, influencing procurement of instruments, reagents, and software licensing. For laboratories that rely on cross-border supply of sequencing instruments and specialized reagents, tariff-related cost adjustments can translate into altered procurement timelines and modified capital planning. These dynamics, in turn, affect laboratory throughput and the pace at which new projects are initiated, particularly for organizations operating on tight grant cycles or seasonal agricultural timelines.

Beyond direct cost impacts, tariffs can complicate collaborative research arrangements that depend on timely shipment of samples, consumables, or modular instrument components. As a result, teams increasingly consider regional sourcing alternatives, longer lead times, and contractual safeguards to preserve research continuity. Trade measures also raise the profile of localized manufacturing and distribution strategies, which some stakeholders pursue to mitigate exposure. Importantly, regulatory and customs processes tied to tariff implementation can lengthen clearance times for biological materials and hardware, thereby creating operational bottlenecks that require proactive logistical planning and transparent supplier communication to manage.

Deep segmentation insights revealing how product types, technology platforms, service models, applications, and end users create differentiated value pools across plant genomics

A nuanced understanding of market segmentation clarifies where value is created and which capabilities merit investment. Based on product type, stakeholders classify offerings among instruments, reagents and consumables, services, and software, each carrying distinct procurement cycles and support expectations. Instruments require capital planning and long-term service agreements, reagents and consumables drive recurring spend and quality control concerns, services deliver outcome-oriented capacity for labs lacking in-house capability, and software underpins data processing, visualization, and decision support.

Based on technology, the domain encompasses gene editing, polymerase chain reaction, and sequencing platforms. Gene editing itself is differentiated by CRISPR, transcription activator-like effector nucleases, and zinc finger nucleases, each varying in specificity, delivery approaches, and regulatory scrutiny. Polymerase chain reaction modalities include digital PCR, quantitative PCR, and reverse transcription PCR, which serve distinct applications from absolute quantitation to expression analysis. Sequencing technologies span next-generation, Sanger, and third-generation modalities, offering trade-offs among read length, throughput, and error profiles.

Based on service model, organizations rely on consulting, contract research, and data analysis to augment internal capabilities and accelerate project timelines. These models enable access to specialized expertise and infrastructure without the fixed costs of full ownership. Based on application, use cases map to agriculture, diagnostics, and research. Agricultural applications focus on disease resistance, genetic improvement, and yield enhancement, while diagnostics emphasize genetic testing, infectious disease testing, and prenatal testing. Research spans basic inquiry, biomarker discovery, and drug discovery, each demanding different experimental designs and validation pathways. Based on end users, adoption patterns are driven by academic and research institutes, agricultural firms, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies, with each group prioritizing different performance attributes, compliance needs, and service expectations.

Regional dynamics and strategic implications across the Americas, Europe-Middle East-Africa, and Asia-Pacific that influence adoption, regulation, and infrastructure choices

Regional dynamics shape access to talent, capital infrastructure, and regulatory frameworks, and three geographic clusters merit focused attention. The Americas region exhibits a diverse mix of academic excellence, venture activity, and established industrial players, supporting rapid translation of genomic tools into commercial pipelines. Infrastructure strength and proximity to large agricultural markets encourage adoption of both high-throughput sequencing and applied gene editing programs, while regional regulatory processes influence trial design and product deployment.

Europe, the Middle East, and Africa present a varied landscape with progressive research hubs, differentiated regulatory environments, and distinct agricultural priorities. Fragmentation across jurisdictions creates both challenges and opportunities: harmonized regulatory approaches can accelerate cross-border collaborations, whereas divergent rules incentivize localized strategies and partnerships with regional service providers. Meanwhile, parts of the region emphasize sustainable agriculture and biodiversity conservation, which affects research agendas and stakeholder engagement models.

Asia-Pacific is characterized by fast-growing R&D investments, an expanding base of skilled practitioners, and strong governmental initiatives to modernize agriculture and public health diagnostics. Supply chain integration across manufacturing hubs and end-user markets enables scale advantages for reagent and instrument suppliers, while national policies around biotechnology and biosafety shape permissible applications and commercialization pathways. Each region's unique mix of scientific capacity, policy orientation, and market demand requires tailored go-to-market approaches and localized partnerships to maximize impact.

Competitive dynamics and strategic playbooks that highlight platform integration, service bundling, and data governance as differentiators among plant genomics providers

Leading players in the plant genomics ecosystem differentiate themselves through integrated portfolios that combine instrumentation, consumables, software, and service offerings. Companies that align product roadmaps with user workflows and emphasize interoperability tend to reduce adoption friction and increase customer lifetime engagement. Strategic partnerships between instrument manufacturers, reagent suppliers, and specialized service providers create bundled solutions that appeal to organizations seeking turnkey capabilities.

Innovation pathways often center on platform scalability, ease of use, and data integration. Vendors who provide robust training, certification, and application support lower the barrier to adoption in non-traditional end users, such as agricultural firms with limited molecular biology experience. Additionally, firms that invest in secure, compliant cloud environments and transparent data governance practices address a growing set of buyer concerns related to data residency and reproducibility. Contract research organizations and consulting providers that can demonstrate reproducible project outcomes and flexible delivery models are increasingly selected by clients prioritizing speed to insight over capital investment in new instrumentation.

Practical and prioritized actions for leaders to strengthen supply resilience, scale operations, and align commercial models with evolving user needs

Industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term capability building. First, diversifying supply chains and qualifying multiple vetted suppliers for critical reagents and instrument components will reduce operational disruption and support continuity during tariff-driven market shifts. Second, investing in modular automation and standardized data pipelines enhances throughput while lowering the personnel burden of routine processes, thereby improving reproducibility and enabling scale.

Third, deepen collaborations with regional partners and contract research providers to access local expertise, share risk, and accelerate project timelines without overcommitting fixed capital. Fourth, prioritize transparent data governance and cybersecurity measures to build trust with end users and satisfy evolving regulatory requirements. Fifth, design flexible commercial models that combine hardware, consumables, and outcome-oriented services to meet diverse buyer preferences. Finally, build cross-functional teams that integrate domain scientists, bioinformaticians, and regulatory specialists to ensure that product development and deployment decisions align with real-world operational constraints and stakeholder expectations.

A rigorous mixed-method research approach combining expert interviews, technical literature review, and iterative validation to ensure practical and actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robustness and relevance. Primary inputs include structured interviews with domain experts across academia, industry, and clinical settings, alongside consultations with laboratory operations managers and procurement specialists to validate operational constraints and purchasing behaviors. Secondary inputs encompass peer-reviewed literature, regulatory documents, technical white papers, and publicly available product specifications, which together provide a technical baseline for comparative assessment.

Data triangulation was applied to reconcile insights from diverse sources, and thematic analysis identified recurrent operational challenges, technology adoption drivers, and supplier positioning. Throughout the process, iterative validation sessions with subject matter experts refined interpretations and ensured that practical considerations-such as reagent lifecycle management, instrument calibration needs, and data interoperability requirements-were accurately represented. The resulting framework integrates product, technology, service, application, and end-user perspectives to support decision making without relying on single-source assumptions.

Synthesis of practical implications and strategic priorities that leaders must address to convert plant genomics advancements into reliable operational and commercial outcomes

The collective evidence highlights a plant genomics ecosystem in transition, where technological maturity, data complexity, and supply chain considerations intersect to redefine strategic priorities. Stakeholders who invest in interoperable platforms, resilient procurement models, and outcome-oriented service partnerships are better positioned to translate genomic capabilities into operational impact. Equally important is the cultivation of multidisciplinary teams that can bridge wet-lab execution with bioinformatic interpretation and regulatory navigation.

Looking ahead, success will be determined less by single technology choices and more by the ability to assemble adaptable workflows that meet specific application needs, whether in agriculture, diagnostics, or foundational research. Organizations that balance near-term operational resilience with long-term investments in automation, data governance, and regional partnerships will navigate present challenges while preserving optionality to capitalize on future innovations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in CRISPR-Cas mediated gene editing for drought-resistant crop varieties enabling climate adaptation
  • 5.2. Integration of artificial intelligence and machine learning to accelerate plant trait discovery processes
  • 5.3. Development of high-throughput single-cell sequencing platforms for plant stress response profiling
  • 5.4. Commercialization of precision gene-editing technologies to enhance crop yield and nutritional content
  • 5.5. Implementation of pan-genome analysis to uncover genetic diversity in major cereal crops
  • 5.6. Application of targeted epigenome editing tools to regulate plant growth and environmental resilience
  • 5.7. Utilization of integrated multi-omics data to predict complex trait inheritance in breeding programs
  • 5.8. Expansion of synthetic biology approaches to engineer photosynthetic efficiency in staple crops
  • 5.9. Adoption of portable nanopore sequencing systems for real-time pathogen detection in agricultural fields
  • 5.10. Global regulatory harmonization efforts influencing acceptance of genetically modified plant products

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plant Genomics Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
  • 8.3. Services
  • 8.4. Software

9. Plant Genomics Market, by Technology

  • 9.1. Gene Editing
    • 9.1.1. Crispr
    • 9.1.2. Transcription Activator Like Effector Nucleases
    • 9.1.3. Zinc Finger Nucleases
  • 9.2. Polymerase Chain Reaction
    • 9.2.1. Digital Polymerase Chain Reaction
    • 9.2.2. Quantitative Polymerase Chain Reaction
    • 9.2.3. Reverse Transcription Polymerase Chain Reaction
  • 9.3. Sequencing
    • 9.3.1. Next Generation Sequencing
    • 9.3.2. Sanger Sequencing
    • 9.3.3. Third Generation Sequencing

10. Plant Genomics Market, by Service Model

  • 10.1. Consulting
  • 10.2. Contract Research
  • 10.3. Data Analysis

11. Plant Genomics Market, by Application

  • 11.1. Agriculture
    • 11.1.1. Disease Resistance
    • 11.1.2. Genetic Improvement
    • 11.1.3. Yield Improvement
  • 11.2. Diagnostics
    • 11.2.1. Genetic Testing
    • 11.2.2. Infectious Disease Testing
    • 11.2.3. Prenatal Testing
  • 11.3. Research
    • 11.3.1. Basic Research
    • 11.3.2. Biomarker Discovery
    • 11.3.3. Drug Discovery

12. Plant Genomics Market, by End Users

  • 12.1. Academic & Research Institutes
  • 12.2. Agriculture Firms
  • 12.3. Hospitals & Diagnostic Laboratories
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Plant Genomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Plant Genomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Plant Genomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. BGI Genomics Co., Ltd.
    • 16.3.4. QIAGEN N.V.
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. PerkinElmer, Inc.
    • 16.3.7. Pacific Biosciences of California, Inc.
    • 16.3.8. Oxford Nanopore Technologies Limited
    • 16.3.9. Eurofins Scientific SE
    • 16.3.10. Merck KGaA

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PLANT GENOMICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PLANT GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PLANT GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PLANT GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PLANT GENOMICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PLANT GENOMICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PLANT GENOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PLANT GENOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PLANT GENOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PLANT GENOMICS MARKET SIZE, BY CRISPR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PLANT GENOMICS MARKET SIZE, BY TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PLANT GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PLANT GENOMICS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PLANT GENOMICS MARKET SIZE, BY REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PLANT GENOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PLANT GENOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PLANT GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PLANT GENOMICS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PLANT GENOMICS MARKET SIZE, BY CONTRACT RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PLANT GENOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PLANT GENOMICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PLANT GENOMICS MARKET SIZE, BY YIELD IMPROVEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PLANT GENOMICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PLANT GENOMICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PLANT GENOMICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PLANT GENOMICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PLANT GENOMICS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PLANT GENOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PLANT GENOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PLANT GENOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PLANT GENOMICS MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PLANT GENOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PLANT GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PLANT GENOMICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY AGRICULTURE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA PLANT GENOMICS MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY SERVICE MODEL, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PLANT GENOMICS MARKET SIZE, BY AP